Drug manufacturer Merck says it is imposing mandatory conditions on 340B pricing when hospitals use contract pharmacies due to “very low” participation in its voluntary 340B program integrity initiative.
Groups that represent hospitals in the drug discount program say Merck is breaking federal law. The U.S. Health and Human Services Department (HHS) should stop Merck immediately, force it to repay hospitals for overcharges, and punish it with civil monetary penalties, the groups say.
Drug manufacturer Merck says it is imposing mandatory conditions on 340B pricing when hospitals use contract pharmacies due to “very low” participation in its voluntary 340B program integrity initiative.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
